Table 2 HIV infection and ART treatment characteristics, in 2004 and 2014
2004 | 2014 | p-value | |
|---|---|---|---|
n = 2138 | n = 2138 | ||
Time since HIV diagnosis (years), mean (SD) | 10.5 (5.5) | 20.5 (5.5)* | < 0.0001 |
CD4 count (cells/mm3), median (IQR) | 457 (321;634) | 647 (479;858) | < 0.0001 |
CD4 count, strata, n (%) | < 0.0001 | ||
≥ 500 | 879 (43.6) | 1451 (72.0) | |
351–500 | 546 (27.1) | 336 (16.7) | |
< 350 | 590 (29.3) | 228 (11.3) | |
Patients with viral suppression (< 50 copies/ml), n (%) | 1021 (50.9) | 1835 (91.5) | < 0.0001 |
Naïve to ART, n (%) | 213 (10.0) | 14 (0.7) | < 0.0001 |
Duration of ART (months), mean (SD) | 77 (39) | 190 (46)* | < 0.0001 |
Current ART drug class, n (%) | < 0.0001 | ||
2 NRTIs + 1 PI/r | 505 (23.6) | 693 (32.4) | |
2 NRTIs + 1 NNRTI | 467 (21.8) | 690 (32.3) | |
2 NRTIs + II | 0 (0.0) | 138 (6.5) | |
Other regimens | 751 (35.1) | 559 (26.1) | |
No treatment | 415 (19.4) | 58 (2.7) | |
AIDS stage, n (%) | 442 (20.7) | 525 (24.6)* | < 0.0001 |